Actively Recruiting

All Genders
NCT02026388

Rare Kidney Stone Consortium Biobank

Led by Mayo Clinic · Updated on 2025-07-22

2000

Participants Needed

1

Research Sites

891 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

CONDITIONS

Official Title

Rare Kidney Stone Consortium Biobank

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of primary hyperoxaluria meeting one or more of the following: liver biopsy confirming enzyme activity below normal; genetic testing confirming mutations for PH types 1, 2, or 3; urinary oxalate excretion over 0.8 mmol/1.73 m2/day without secondary causes; end stage kidney failure with plasma oxalate over 60 umol/L and kidney biopsy or systemic oxalosis; or prior consent in a related study.
  • Diagnosis of Dent disease meeting one or more of the following: identified mutation in CLCN5 gene; low molecular weight proteinuria with hypercalciuria; or low molecular weight proteinuria with nephrocalcinosis.
  • Diagnosis of APRT disease meeting one or more of the following: suspected dihydroxyadeninuria with absent APRT enzyme activity in red blood cells; known APRT mutations; or passage of dihydroxyadenine stones confirmed by stone analysis.
  • Diagnosis of cystinuria meeting one or more of the following: stone analysis showing cystine content; or increased urinary cystine excretion over 250 mg/g creatinine.
  • Being a relative of someone with confirmed primary hyperoxaluria, Dent disease, APRT deficiency, or cystinuria.
Not Eligible

You will not qualify if you...

  • Stone formers who do not meet the inclusion criteria for primary hyperoxaluria, cystinuria, Dent disease, or APRT deficiency.
  • Individuals unwilling or unable to provide consent or assent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

B

Barb M Seide

CONTACT

L

Leah M Knoke

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here